Rare otorhinolaryngologic tumor

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Rare otorhinolaryngologic tumor.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Rare otorhinolaryngologic tumor.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

OXALIPLATIN

(OXALIPLATIN)standard

Accord Healthcare Inc.

Platinum-based Drug [EPC]

12.1 Mechanism of Action Oxaliplatin undergoes nonenzymatic conversion in physiologic solutions to active derivatives via displacement of the labile o...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare otorhinolaryngologic tumor.
Search all trials →
Search clinical trials for Rare otorhinolaryngologic tumor

Recent News & Research

1 article
BREAKINGFDA

FDA Approves OXALIPLATIN

OXALIPLATIN (OXALIPLATIN) received FDA approval.

Read ↗

Browse all Rare otorhinolaryngologic tumor news →

Specialist Network

Top 6 by expertise

View all Rare otorhinolaryngologic tumor specialists →

Quick Actions